InsiderTrades

Form 4 for CL Colgate-Palmolive

Accepted 2023-05-10 00:00:00 ET · period of report 2023-05-08 · accession 0001225208-23-005680 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-10 2023-05-08 CL Parameswaran Prabha Grp Pres, Growth, Strategy M - OptEx $73.00 +64.4K 76.8K +518% +$4.70M
D 2023-05-10 2023-05-08 CL Parameswaran Prabha Grp Pres, Growth, Strategy S - Sale+OE $80.58 -64.4K 12.4K -84% -$5.19M
D 2023-05-10 2023-05-08 CL Parameswaran Prabha Grp Pres, Growth, Strategy M - OptEx $0.00 -64.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-08 M A 64,373 $73.00 76,800 D — —
2 Common Common Stock 2023-05-08 S D 64,373 $80.58 12,427 D — — (F3) Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.3750 to $80.9300, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Stock Option (Right to Buy) 2023-05-08 M D 64,373 $0.00 0 D $73.00 · — to 2023-09-25 64,373 Common Stock (F4) Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.